Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Immunol ; 39: 60-65, 2016 11.
Article in English | MEDLINE | ID: mdl-27568336

ABSTRACT

Primary hyperoxaluria is a genetic disorder in glyoxylate metabolism that leads to systemic overproduction of oxalate. Functional deficiency of alanine-glyoxylate aminotransferase in this disease leads to recurrent nephrolithiasis, nephrocalcinosis, systemic oxalosis, and kidney failure. The aim of this study was to determine the molecular etiology of kidney transplant loss in a young Tunisian individual. We present a young man with end-stage renal disease who received a kidney allograft and experienced early graft failure. There were no improvement in kidney function; he required hemodialysis and graft biopsy revealed calcium oxalate crystals, which raised suspicion of primary hyperoxaluria. Genetic study in the AGXT gene by PCR direct sequencing identified three missense changes in heterozygote state: the p. Gly190Arg mutation next to two other novels not previously described. The classification of the deleterious effect of the missense changes was developed using the summered results of four different mutation assessment algorithms, SIFT, PolyPhen, Mutation Taster, and Align-GVGD. This system classified the changes as polymorphism in one and as mutation in other. The patient was compound heterozygous mutations. Structural analysis showed that the novel mutation, p.Pro28Ser mutation, affects near the dimerization interface of AGT and positioned on binding site instead of the inhibitor, amino-oxyacetic acid (AOA). With the novel AGXT mutation, the mutational spectrum of this gene continues to broaden in our population. The diagnosis of PH1 was not recognized until after renal transplant with fatal consequences, which led us to confirm the importance of screening before planning for kidney transplantation in population with a relatively high frequency of AGXT mutation carriers.


Subject(s)
Graft Rejection/genetics , Hyperoxaluria, Primary/genetics , Kidney Failure, Chronic/therapy , Kidney Transplantation , Kidney/metabolism , Mutation, Missense/genetics , Transaminases/genetics , Adult , Calcium Oxalate/metabolism , DNA Mutational Analysis , Fatal Outcome , Genetic Testing , Genotype , Glyoxylates/metabolism , Humans , Kidney/immunology , Male , Pedigree , Polymorphism, Genetic , Tunisia , Young Adult
2.
Infect Genet Evol ; 18: 132-44, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23684631

ABSTRACT

Group A rotaviruses (RVA) are the leading cause of severe gastroenteritis in infants and young children worldwide. Due to their epidemiological complexity, it is important to compare the genetic characteristics of vaccine strains with the RVA strains circulating before the introduction of the vaccine in the Tunisian immunization program. In the present study, the nucleotide sequences of VP7 and VP8∗ (n=31), the main targets for neutralizing antibodies, were determined. Comparison of antigenic epitopes of 11 G1P[8], 12 G2P[4], 4 G3P[8], 2 G4P[8], 1 G6P[9] and 1 G12P[8] RVA strains circulating in Tunisia from 2006 to 2011 with the RVA strains present in licensed vaccines showed that multiple amino acid differences existed in or near putative neutralizing domains of VP7 and VP8∗. The Tunisian G3 RVA strains were found to possess a potential extra N-linked glycosylation site. The Tunisian G4 RVA were closely related to the G4 vaccine strain in RotaTeq, belonging to the same lineage, but the alignment of their VP7 amino acids revealed an insertion of an asparagine residue at position 76 which is close to a glycosylation site (aa 69-71). Despite several differences detected between Tunisian and vaccine strains, which may affect binding of neutralizing antibodies, both vaccines are known to protect against the vast majority of the circulating genotypes, providing an indication of the high vaccine efficiency that can be expected in a future rotavirus immunization program.


Subject(s)
Antigens, Viral/genetics , Capsid Proteins/genetics , RNA-Binding Proteins/genetics , Rotavirus Infections/virology , Rotavirus Vaccines/administration & dosage , Rotavirus/genetics , Rotavirus/immunology , Viral Nonstructural Proteins/genetics , Amino Acid Sequence , Antigens, Viral/immunology , Capsid Proteins/immunology , Epitopes/genetics , Evolution, Molecular , Genotype , Humans , Models, Molecular , Molecular Sequence Data , Mutation , Phylogeny , RNA-Binding Proteins/immunology , Rotavirus/isolation & purification , Rotavirus Infections/epidemiology , Rotavirus Vaccines/genetics , Rotavirus Vaccines/immunology , Sequence Alignment , Tunisia/epidemiology , Viral Nonstructural Proteins/immunology
3.
Phys Chem Chem Phys ; 12(12): 2850-9, 2010 Mar 28.
Article in English | MEDLINE | ID: mdl-20449375

ABSTRACT

Protein flexibility is essential for enzymatic function, ligand binding, and protein-protein or protein-nucleic acid interactions. Normal mode analysis has increasingly been shown to be well suited for studying such flexibility, as it can be used to identify favorable structural deformations that correspond to functional motions. However, normal modes are strictly relevant to a single structure, reflecting a particular minimum on a complex energy surface, and are thus susceptible to artifacts. We describe a new theoretical framework for determining "consensus" normal modes from a set of related structures, such as those issuing from a short molecular dynamics simulation. This approach is more robust than standard normal mode analysis, and provides higher collectivity and symmetry properties. In an application to HIV-1 protease, the low-frequency consensus modes describe biologically relevant motions including flap opening and closing that can be used in interpreting structural changes accompanying the binding of widely differing inhibitors.


Subject(s)
HIV Protease/chemistry , HIV-1 , Molecular Dynamics Simulation , Humans , Magnetic Resonance Spectroscopy , Models, Molecular
4.
PLoS One ; 5(2): e9142, 2010 Feb 18.
Article in English | MEDLINE | ID: mdl-20174625

ABSTRACT

Small G-proteins of the superfamily Ras function as molecular switches, interacting with different cellular partners according to their activation state. G-protein activation involves the dissociation of bound GDP and its replacement by GTP, in an exchange reaction that is accelerated and regulated in the cell by guanine-nucleotide exchange factors (GEFs). Large conformational changes accompany the exchange reaction, and our understanding of the mechanism is correspondingly incomplete. However, much knowledge has been derived from structural studies of blocked or inactive mutant GEFs, which presumably closely represent intermediates in the exchange reaction and yet which are by design incompetent for carrying out the nucleotide exchange reaction. In this study we have used comparative modelling to recreate an exchange-competent form of a late, pre-GDP-ejection intermediate species in Arf1, a well-characterized small G-protein. We extensively characterized three distinct models of this intermediate using molecular dynamics simulations, allowing us to address ambiguities related to the mutant structural studies. We observed in particular the unfavorable nature of Mg2+ associated forms of the complex and the establishment of closer Arf1-GEF contacts in its absence. The results of this study shed light on GEF-mediated activation of this small G protein and on predicting the fate of the Mg ion at a critical point in the exchange reaction. The structural models themselves furnish additional targets for interfacial inhibitor design, a promising direction for exploring potentially druggable targets with high biological specificity.


Subject(s)
GTP-Binding Proteins/chemistry , Guanine Nucleotide Exchange Factors/chemistry , Molecular Dynamics Simulation , Nucleotides/chemistry , ADP-Ribosylation Factor 1/chemistry , ADP-Ribosylation Factor 1/metabolism , Algorithms , Energy Transfer , GTP-Binding Proteins/metabolism , Guanine Nucleotide Exchange Factors/metabolism , Guanosine Diphosphate/chemistry , Guanosine Diphosphate/metabolism , Guanosine Triphosphate/chemistry , Guanosine Triphosphate/metabolism , Humans , Magnesium/chemistry , Magnesium/metabolism , Models, Chemical , Models, Molecular , Molecular Structure , Nucleotides/metabolism , Protein Binding , Protein Conformation , Static Electricity
5.
Chembiochem ; 10(8): 1349-59, 2009 May 25.
Article in English | MEDLINE | ID: mdl-19415706

ABSTRACT

Breaking ties: The antitumour protein, neocarzinostatin (NCS), is one of the few drug-carrying proteins used in human therapeutics. However, the presence of disulfide bonds limits this protein's potential development for many applications. This study describes a generic directed-evolution approach starting from NCS-3.24 (shown in the figure complexed with two testosterone molecules) to engineer stable disulfide-free NCS variants suitable for a variety of purposes, including intracellular applications.The chromoprotein neocarzinostatin (NCS) has been intensively studied for its antitumour properties. It has recently been redesigned as a potential drug-carrying scaffold. A potential limit of this protein scaffold, especially for intracellular applications, is the presence of disulfide bonds. The objective of this work was to create a disulfide-free NCS-derived scaffold. A generic targeted approach was developed by using directed evolution methods. As a starting point we used a previously engineered NCS variant in which a hapten binding site had been created. A library was then generated in which cysteine Cys88 and Cys93 and neighbouring residues were randomly substituted. Variants that preserved the hapten binding function were selected by phage display and further screened by colony filtration methods. Several sequences with common features emerged from this process. The corresponding proteins were expressed, purified and their biophysical properties characterised. How these selected sequences rescued folding ability and stability of the disulfide-free protein was carefully examined by using calorimetry and the results were interpreted with molecular simulation techniques.


Subject(s)
Antineoplastic Agents/chemistry , Disulfides/chemistry , Zinostatin/chemistry , Amino Acid Sequence , Antineoplastic Agents/metabolism , Base Sequence , Computer Simulation , Crystallography, X-Ray , Directed Molecular Evolution , Mutagenesis, Site-Directed , Mutant Proteins/chemistry , Mutant Proteins/genetics , Mutant Proteins/metabolism , Peptide Library , Protein Binding , Protein Engineering , Testosterone/chemistry , Thermodynamics , Zinostatin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...